ISPC vs PPL · rev $9.3M vs P/E 22, rev $8.46B
iSpecimen Inc (ISPC) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
ISPC currently screens at market cap $4.4M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the ISPC and PPL stock pages for the full models.
Not investment advice.